Financials
- Market Capitalization 1.74 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-63.19
売上高対価格比率
15.2
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2065 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.40 USD | +1.80% | -0.29% | +12.21% | -25.93% | 1.82 B USD | ||
| 2080 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.73 USD | -1.09% | -2.75% | +20.21% | -7.22% | 1.78 B USD | ||
| 2092 | FTRE Fortrea Holdings Inc. - Common Stock | 18.26 USD | -0.60% | -0.60% | -5.09% | +89.42% | 1.74 B USD | ||
| 2104 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.41 USD | +0.62% | -2.90% | +2.10% | +17.64% | 1.73 B USD |